Follow The Filings

CPIX Cumberland Pharmaceuticals

Cumberland Pharmaceuticals earnings company data as of 7:49 PM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 3 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by CPIX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CPIX insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales

No open-market buys or sales on file.

Also filed in the last 12 months, not counted as buying or selling: 192 other transactions, 6 stock grants, and 1 share withholding for taxes.

SEC filings

Recent issuer filings from EDGAR, 21 shown.

Filed Form Detail Links
8-K 8.01
8-K/A 5.07
8-K 7.01
10-Q
8-K 2.02,9.01
8-K 8.01
8-K 1.01,1.02,2.01,5.02,8.01,9.01
8-K 5.07
10-Q
8-K 2.02,9.01
8-K 5.07
8-K 1.01,7.01,8.01,9.01
DEFA14A
DEF 14A
10-K
DEFA14A
8-K 2.02,9.01
SCHEDULE 13G —
8-K 8.01
8-K 1.01,2.03
10-Q

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.